Dx & Vx Co Ltd
KOSDAQ:180400
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dx & Vx Co Ltd
KOSDAQ:180400
|
KR |
|
M
|
Manning Ventures Inc
CNSX:MANN
|
CA |
|
J
|
JB Hi-Fi Ltd
F:JB3
|
AU |
Intrinsic Value
The intrinsic value of Dx & Vx Co Ltd (180400) under the Base Case is 1 048.14 KRW per share. Compared with the current market price of 1 982 KRW, the stock appears Overvalued by 47% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Dx & Vx Does
Dx & Vx Co., Ltd. engages in the development of molecular diagnostic products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-12-15. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.
- Headquarters
- Korea KR
- IPO date
- Dec 15, 2014
Revenue & Expenses Breakdown
Dx & Vx Co Ltd
Earnings Waterfall
Dx & Vx Co Ltd
The intrinsic value for Dx & Vx Co Ltd (180400) under the Base Case is 1 048.14 KRW.
Compared with the current market price of 1 982 KRW, the stock appears Overvalued by 47% .